Arrowhead Pharmaceuticals, Inc. (ARWR)
86.74
-0.37
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
86.74
0.00 (0.00%)
After-Hours: 19:54
Arrowhead Pharmaceuticals Shareholders Equity (Quarterly) : 465.53M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 465.53M |
| March 31, 2026 | 613.98M |
| December 31, 2025 | 568.42M |
| September 30, 2025 | 466.05M |
| June 30, 2025 | 522.31M |
| March 31, 2025 | 683.32M |
| December 31, 2024 | 52.59M |
| September 30, 2024 | 185.44M |
| June 30, 2024 | 330.55M |
| March 31, 2024 | 483.79M |
| December 31, 2023 | 160.41M |
| September 30, 2023 | 271.34M |
| June 30, 2023 | 364.83M |
| March 31, 2023 | 446.77M |
| December 31, 2022 | 377.04M |
| September 30, 2022 | 398.52M |
| June 30, 2022 | 453.93M |
| March 31, 2022 | 452.27M |
| December 31, 2021 | 372.56M |
| September 30, 2021 | 408.82M |
| June 30, 2021 | 436.89M |
| March 31, 2021 | 445.55M |
| December 31, 2020 | 454.47M |
| September 30, 2020 | 461.78M |
| June 30, 2020 | 493.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 494.12M |
| December 31, 2019 | 500.08M |
| September 30, 2019 | 244.59M |
| June 30, 2019 | 226.23M |
| March 31, 2019 | 201.20M |
| December 31, 2018 | 172.06M |
| September 30, 2018 | 95.80M |
| June 30, 2018 | 102.31M |
| March 31, 2018 | 114.27M |
| December 31, 2017 | 70.75M |
| September 30, 2017 | 81.42M |
| June 30, 2017 | 90.10M |
| March 31, 2017 | 93.89M |
| December 31, 2016 | 97.76M |
| September 30, 2016 | 95.58M |
| June 30, 2016 | 59.98M |
| March 31, 2016 | 74.48M |
| December 31, 2015 | 92.92M |
| September 30, 2015 | 110.18M |
| June 30, 2015 | 131.30M |
| March 31, 2015 | 144.75M |
| December 31, 2014 | 146.26M |
| September 30, 2014 | 166.54M |
| June 30, 2014 | 186.36M |
| March 31, 2014 | 191.40M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.528B |
| Intellia Therapeutics, Inc. | 727.71M |
| Denali Therapeutics, Inc. | 835.18M |
| Twist Bioscience Corp. | 445.74M |
| Revolution Medicines, Inc. | 2.606B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.112B |
| Total Liabilities (Quarterly) | 1.646B |
| Debt to Equity Ratio | 2.956 |
| Current Ratio | 5.899 |
| Net Debt Paydown Yield | -1.11% |